Style | Citing Format |
---|---|
MLA | Karimi A, et al.. "A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review." International Journal of Rheumatic Diseases, vol. 25, no. 8, 2022, pp. 827-843. |
APA | Karimi A, Azar PS, Kadkhodayi M, Tandorost A, Vajdi M, Shoorei H, Farhangi MA (2022). A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review. International Journal of Rheumatic Diseases, 25(8), 827-843. |
Chicago | Karimi A, Azar PS, Kadkhodayi M, Tandorost A, Vajdi M, Shoorei H, Farhangi MA. "A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review." International Journal of Rheumatic Diseases 25, no. 8 (2022): 827-843. |
Harvard | Karimi A et al. (2022) 'A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review', International Journal of Rheumatic Diseases, 25(8), pp. 827-843. |
Vancouver | Karimi A, Azar PS, Kadkhodayi M, Tandorost A, Vajdi M, Shoorei H, et al.. A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review. International Journal of Rheumatic Diseases. 2022;25(8):827-843. |
BibTex | @article{ author = {Karimi A and Azar PS and Kadkhodayi M and Tandorost A and Vajdi M and Shoorei H and Farhangi MA}, title = {A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review}, journal = {International Journal of Rheumatic Diseases}, volume = {25}, number = {8}, pages = {827-843}, year = {2022} } |
RIS | TY - JOUR AU - Karimi A AU - Azar PS AU - Kadkhodayi M AU - Tandorost A AU - Vajdi M AU - Shoorei H AU - Farhangi MA TI - A Comprehensive Insight Into Effects of Resveratrol on Molecular Mechanism in Rheumatoid Arthritis: A Literature Systematic Review JO - International Journal of Rheumatic Diseases VL - 25 IS - 8 SP - 827 EP - 843 PY - 2022 ER - |